Are you comfortable prescribing HRT?
POLL: How do you compare with your colleagues in your comfort level for prescribing hormone replacement therapy for symptoms of menopause.
Vasomotor symptoms and other symptoms related to decreased estrogen levels from menopause are costly to women as well as the health care system. Women who experience them are burdened with hot flashes, sleep disturbances, and a variety of other issues that can diminish their quality of both home and work life, including dyspareunia, anxiety, depression, irritability, and memory impairment. Also, research has shown that untreated vasomotor symptoms are associated with significant increases in healthcare utilization, work loss, and cost burden.
The one treatment that most effectively manages many of these symptoms is hormone therapy, but an analysis has shown that the use of hormone replacement therapy is associated with an increased risk of the two most common forms of ovarian cancer. Also, another analysis has shown that HRT isn't cardioprotective.
Considering these new findings, how comfortable are you in prescribing HRT to women who experience moderate to severe vasomotor symptoms? (Assume there are no contraindications based on patient history.)
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More
Shared genetics found between anti-Müllerian hormone and age at menopause
December 4th 2024In a recent study, an inverse relationship was discovered between anti-Müllerian hormone levels and early menopause, highlighting the need to develop interventions for fertility preservation based on genetics.
Read More
